Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, novembre 18
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Omada Health Inc
OMDA
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$14.25
0.17
1.21%
Dern. MÀJ: Nov 18, 9:04 AM
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Options
Rapport sur les stocks
Omada Health Financials
Omada Health (OMDA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Omada Health Raises FY2026 Sales Guidance from $334.000M-$340.000M to $344.000M-$346.000M vs $338.537M Est
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $334.000 million-$340.000 million to $344.000 million-$346.000 million vs $338.537 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q3 EPS $0.10 Beats $0.02 Estimate, Sales $91.000M Beat $85.676M Estimate
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.02 by 400 percent. This is a 600 percent increase over losses of $(0.02) per share from the same
Benzinga Newsdesk
PRO
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $322.000 million-$330.000 million to $334.000 million-$340.000 million vs $327.789 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.01) by 900 percent. This is a 133.33 percent increase over losses of $(0.24) per share from the
Benzinga Newsdesk
PRO
Omada Health Raises FY2026 Sales Guidance from $312.000M-$322.000M to $322.000M-$330.000M vs $318.789M Est.
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $312.000 million-$322.000 million to $322.000 million-$330.000 million vs $318.789 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q1 EPS $(0.05) Beats $(0.09) Estimate, Sales $78.048M Beat $74.036M Estimate.
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 95.65 percent increase over losses of $(1.15) per share from the
Benzinga Newsdesk